Studies have also shown that SOX2 may be regulated at a transcriptional level via epigenetics, leading to SOX2 silencing in some human cancers, correlating to more aggressive biological behaviour and poorer overall prognosis [18, 27–29]. This evidence concerns the gene SOX2 and cancer.